List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 22 studies with search of:   "Metrorrhagia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®
Conditions: Breakthrough Bleeding;   Breakthrough Spotting
Interventions: Other: remove ring if bleeding or spotting occurs more than 5 days;   Other: If bleeding does not remove ring
2 Completed Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Condition: Metrorrhagia
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID);   Drug: Placebo
3 Completed Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Condition: Metrorrhagia
Intervention: Drug: Qlaira (BAY86-5027, SH T00658ID)
4 Completed An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
Condition: Metrorrhagia
Intervention: Drug: Norgestimate/Ethinyl Estradiol tablet
5 Completed An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
Condition: Metrorrhagia
Intervention: Drug: norelgestromin/ethinyl estradiol
6 Recruiting Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
Condition: Metrorrhagia
Intervention: Drug: Femring
7 Recruiting CavatermTM vs TCRE in Women With DUB
Condition: Dysfunctional Uterine Bleeding
Interventions: Device: Thermal Balloon Endometrial Ablation;   Device: Transcervical Resection of the Endometrium
8 Completed Safety of Treatment of Uterine Fibroids With Asoprisnil
Conditions: Fibroid Uterus;   Leiomyoma;   Menorrhagia;   Metrorrhagia;   Uterine Fibroids
Interventions: Drug: Asoprisnil;   Drug: Asoprisnil
9 Completed A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
Conditions: Fibroid Uterus;   Leiomyoma;   Menorrhagia;   Metrorrhagia;   Uterine Fibroids
Interventions: Drug: Asoprisnil;   Drug: Asoprisnil;   Drug: Placebo
10 Completed Study of Asoprisnil in the Treatment of Uterine Fibroids.
Conditions: Fibroid Uterus;   Leiomyoma;   Menorrhagia;   Metrorrhagia;   Uterine Fibroids
Interventions: Drug: Asoprisnil;   Drug: Asoprisnil
11 Completed Treatment of Uterine Fibroids With Asoprisnil(J867)
Conditions: Leiomyoma;   Menorrhagia;   Metrorrhagia
Interventions: Drug: Asoprisnil;   Drug: Asoprisnil;   Drug: Placebo
12 Completed A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Conditions: Leiomyoma;   Menorrhagia;   Metrorrhagia
Interventions: Drug: Asoprisnil;   Drug: Asoprisnil;   Drug: Placebo
13 Completed Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
Conditions: Leiomyoma;   Menorrhagia;   Metrorrhagia
Interventions: Drug: Asoprisnil;   Drug: Asoprisnil
14 Recruiting Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals
Conditions: Migraines;   Bleeding;   Spotting
Interventions: Drug: frovatriptan;   Drug: frovatriptan;   Drug: placebo
15 Completed A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale.
Condition: Breakthrough Bleeding
Interventions: Drug: DR-1031a;   Drug: DR-1031b;   Drug: DR-1031c;   Drug: Seasonale
16 Completed Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)
Conditions: Menorrhagia;   Uterine Bleeding
Interventions: Procedure: hysterectomy;   Procedure: endometrial ablation
17 Completed Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?
Condition: Breakthrough Bleeding
Intervention: Drug: Birth control pills
18 Recruiting Norplant and Irregular Bleeding/Spotting
Conditions: Endometrial Bleeding;   Periodontal Disease
Intervention: Drug: doxycycline
19 Completed Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System
Condition: Menorrhagia
Intervention: Procedure: HerOption Endometrial Cryoablation Therapy
20 Completed Genistein and Endometrial Hyperplasia
Condition: Endometrial Hyperplasia
Interventions: Dietary Supplement: Genivis;   Drug: Norethisterone Acetate;   Other: placebo

Previous Page Studies Shown (1-20) Next (21-22)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services